Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−369.97 MHKD
187.18 M
Om IMMUNOTECH BIOPHARM LTD
Sektor
Bransch
VD
Yu Wang
Huvudkvarter
Beijing
Employees (FY)
210
Grundat
2018
ISIN
KYG4721A1004
FIGI
BBG00VNXQ9M1
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
